miR-197: A novel biomarker for cancers

• miR-197 dysregulates in various cancers.
• miR-197 participates in the developments of tumorgenesis.
• the potential effect of treatment.

microRNAs (miRNAs) are small noncoding RNAs that could regulate post-transcription level through binding to 3′ untranslated region (3′UTR) of target messenger RNAs (mRNAs), which were reported to be related with the incidence and development of diverse neoplasms. Among them, miR-197 was confirmed to play a vital role of oncogene or anti-oncogene in different cancers via targeting key tumorigenic or tumor-suppressive genes. Additionally, miR-197 had extensively been studied in carcinogenesis progression of cancers through various mechanisms, including apoptosis, proliferation, angiogenesis, metastasis, drug resistance and tumor suppressor, and also played a role in prognosis of cancers. In this review, we summarized the roles of miR-197 in cancers and considered it as a potentially novel biomarker for different cancers, offering an alternatively secure and effective tool in molecular targeting cancer treatment.